International, observational registry to investigate the outcome in patients with cardiogenic shock. The primary aim of this study is to investigate the clinical outcome of patients in cardiogenic shock.
There is a focus on interventional therapies, mechanical circulatory support and new cardiovascular therapeutics in patients with cardiogenic shock (CS). The investigators will describe current practice in study sites including concomitant patients with CS. Therefore, the investigators will monitor drug therapies initiated, devices being utilized as well as outcome and side effect of possible interventions
Study Type
OBSERVATIONAL
Enrollment
2,500
University Heart Center
Hamburg, Germany
RECRUITINGAll-cause mortality
by registration office
Time frame: Within 30 days after admission.
Ischemic events, bleeding events, heart failure, sepsis, dialysis.
by survey, number of ischemic events, number of bleeding events, number of patients developing heart failure as well as heart failure severity (NYHA), patients developing terminal kidney failure requiring dialysis.
Time frame: Within 30 days after admission.
All-cause mortality
by registration office
Time frame: Within 12 months after admission.
Ischemic events, bleeding events, heart failure, sepsis, dialysis.
by survey, number of ischemic events, number of bleeding events, number of patients developing heart failure as well as heart failure severity (NYHA), patients developing terminal kidney failure requiring dialysis.
Time frame: Within 12 months after admission.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.